Wolverine Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wolverine Trading’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-334	Closed	-$22K	–	6932
2021 Q1	$22K	Buy	+334	New	+$26K	﹤0.01%	5752
2019 Q3	–	Sell	-157	Closed	-$14K	–	5205
2019 Q2	$14K	Sell	157 -70	-31%	-$8.51K	﹤0.01%	4303
2019 Q1	$34K	Buy	227 +31	+16%	+$5.99K	﹤0.01%	4363
2018 Q4	$29K	Buy	196 +27	+16%	+$5.18K	﹤0.01%	4247
2018 Q3	$41K	Sell	169 -140	-45%	-$33.1K	﹤0.01%	4737
2018 Q2	$76K	Hold	309	–	–	﹤0.01%	4814
2018 Q1	$76K	Buy	309 +150	+94%	+$39.4K	﹤0.01%	4814
2017 Q4	$49K	Sell	159 -112	-41%	-$36.8K	﹤0.01%	4608
2017 Q3	$99K	Buy	+271	New	+$96.2K	﹤0.01%	4075
2017 Q1	–	Sell	-143	Closed	-$32K	–	5207
2016 Q4	$32K	Hold	143	–	–	﹤0.01%	4274
2016 Q3	$33K	Buy	+143	New	+$29.7K	﹤0.01%	4464

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wolverine Trading's DMK Position: Q1 2022 in Review

Wolverine Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2022, closing a stake of 209 shares — an estimated $9K sold.

Wolverine Trading first reported a position in DMK in Q4 2016 and held it in 10 quarters. The position peaked at $195K in Q4 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

Wolverine Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
Wolverine Trading sold 209 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2022, an estimated $9K.
Wolverine Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 10 quarters.
Wolverine Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $195K in Q4 2017.
46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.